Esperion Therapeutics Inc (ESPR)

44.74
NASDAQ : Health Care
Prev Close 44.98
Day Low/High 43.79 / 45.89
52 Wk Low/High 9.40 / 57.38
Avg Volume 749.70K
Exchange NASDAQ
Shares Outstanding 22.59M
Market Cap 1.02B
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Steady Climb Amid Low Volume

Bulls should curb their enthusiasm.

These Are the Best Growth Stocks Right Now in Biotech

These Are the Best Growth Stocks Right Now in Biotech

Top names.

Jobs Report Puts Stocks to Work

Next week's focus will be on earnings.

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

Akebia Therapeutics, Sarepta Therapeutics and Esperion Therapeutics were among the biotech stock movers in premarket trading on June 29.

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $41.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

Huge profits could be on the doorstep for these hot breakout setups.

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $36.51/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

Alibaba, Coherent, Advanced Micro Devices: 'Mad Money' Lightning Round

Jim Cramer is bullish on Alibaba and Coherent; but he's bearish on Esperion Therapeutics.

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap (Monday 4/10/17)

These Sleeper Stocks Are Soaring: Cramer's 'Mad Money' Recap (Monday 4/10/17)

Jim Cramer calls out the greatest American companies you probably never even think about.

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $36.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Esperion Therapeutics, Minerva Neurosciences and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

Here's how to trade six of the most active names on the market this afternoon.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.